Chemillennium International
Over the years, Chemillennium has undergone a remarkable transformation, evolving from a small API trading company to a comprehensive generic drug provider. Today, the company has expanded its operations and established a strong presence in key regions such as Hong Kong, China, India, Singapore, and the UAE. With an extensive network of business relations spanning over 30 countries, Chemillennium has become a trusted partner in the pharmaceutical industry.
Recognizing the changing needs of the market, Chemillennium has diversified its services to include drug formulations, government tenders, and market access. By expanding its capabilities, the company has positioned itself as a reliable partner for generic drug manufacturers. In line with this evolution, the group has recently undergone a rebranding, now known as CHEMILL.
CHEMILL offers comprehensive services to generic drug manufacturers, covering the entire spectrum of the drug development process. From API sourcing to the market access of finished dosage forms (FDFs), the group is committed to providing end-to-end solutions to its clients. By leveraging their extensive experience and global network, CHEMILL Group enables manufacturers to streamline their operations, enhance efficiency, and navigate the complex landscape of the pharmaceutical industry.
With a focus on delivering high-quality products and ensuring regulatory compliance, CHEMILL Group has become a trusted partner for generic drug manufacturers worldwide. The group’s expertise, combined with its commitment to customer satisfaction, positions it as a leader in the market. As the pharmaceutical industry continues to evolve, CHEMILL Group remains dedicated to meeting the diverse needs of its clients and driving innovation in the generic drug sector.
Our Reach in Numbers
Years Experience in Generic Drug Industry in Asia
Years Experience in China
API Clients in Asia
Generic Drug Partners Globally
Countries Served
Retail/Hospital Markets Serviced
Quality, Supply Sustainability, and Value Creation:
- We place the utmost attention on maintaining the highest standards of quality, ensuring that our products meet stringent requirements for safety and efficacy
- Our commitment to supply sustainability means that we prioritize the long-term availability and reliability of the products we provide to the market
- Value creation is central to our organizational culture. We understand that value can vary among different market segments and over time, and we are dedicated to delivering the specific value that our customers seek
Our Stand:
Empowering clients for market success and sustainable growth.
Accessible, Safe, Effective, Affordable Medicines for All.
Our Primary Commitments
- Quality and Safety above all. Our unwavering commitment to supplying products that meet rigorous standards ensures the well-being and trust of our customers and end consumers.
- Ensuring timely and equitable access to safe, effective, and affordable medicines, we contribute to the well-being of patients worldwide
- Improving the efficiency of drug production and reducing costs for generic drug product manufacturers. By optimizing supply sources, processes and streamlining operations, we enable our partners to enhance their productivity and competitiveness.
- Consistently generating value for all our stakeholders, including our clients, partners, employees, and shareholders. Through collaborative partnerships and innovative solutions, we aim to create mutual success and growth.
- Offer drug manufacturers with a diverse range of options, empowering them to excel in delivering value to patients and healthcare systems.
- Actively create opportunities for our principles and partners, fostering a dynamic business environment where all stakeholders can thrive.
Get In Touch
